MedPacto Files Patent Applications in 22 Jurisdictions

매일경제 reports that MedPacto, a newly founded drug development firm, made a public announcement on the 2nd. The company disclosed that it has submitted patent applications. Applications cover its innovations across 22 jurisdictions. MedPacto aims to protect its research and development outputs. The filings represent an early step in the company's commercialization strategy. The announcement underscores the firm's focus on intellectual property. Industry observers note the significance for a newcomer in the pharmaceutical sector. Future updates may reveal which specific technologies are being patented.